Fig. 4From: A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patientsForest plots of the pooled risk ratios for (a) target vessel revascularization (TVR) and (b) target lesion revascularization (TLR)Back to article page